View on Pubmed.gov 21944779 | View on doi.org 10.1016/j.neuro...
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.
- Neuromuscular Diseases Research Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
ITALSGEN Consortium
- Andrea Calvo,
- Stefania Cammarosano,
- Cristina Moglia,
- Antonio Canosa,
- Sara Gallo,
- Maura Brunetti,
- Irene Ossola,
- Gabriele Mora,
- Kalliopi Marinou,
- Laura Papetti,
- Amelia Conte,
- Marco Luigetti,
- Vincenzo La Bella,
- Rossella Spataro,
- Tiziana Colletti,
- Stefania Battistini,
- Fabio Giannini,
- Claudia Ricci,
- Claudia Caponnetto,
- Gianluigi Mancardi,
- Paola Mandich,
- Fabrizio Salvi,
- Ilaria Bartolomei,
- Jessica Mandrioli,
- Patrizia Sola,
- Massimo Corbo,
- Christian Lunetta,
- Silvana Penco,
- Maria Rosaria Monsurrò,
- Gioacchino Tedeschi,
- Francesca Luisa Conforti,
- Paolo Volanti,
- Gianluca Floris,
- Antonino Cannas,
- Valeria Piras,
- Maria Rita Murru,
- Maria Giovanna Marrosu,
- Maura Pugliatti,
- Anna Ticca,
- Isabella Simone,
- Giancarlo Logroscino.
Abstract
The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) locus contains one of the last major unidentified autosomal-dominant genes underlying these common neurodegenerative diseases. We have previously shown that a founder haplotype, covering the MOBKL2b, IFNK, and C9ORF72 genes, is present in the majority of cases linked to this region. Here we show that there is a large hexanucleotide (GGGGCC) repeat expansion in the first intron of C9ORF72 on the affected haplotype. This repeat expansion segregates perfectly with disease in the Finnish population, underlying 46.0% of familial ALS and 21.1% of sporadic ALS in that population. Taken together with the D90A SOD1 mutation, 87% of familial ALS in Finland is now explained by a simple monogenic cause. The repeat expansion is also present in one-third of familial ALS cases of outbred European descent, making it the most common genetic cause of these fatal neurodegenerative diseases identified to date.
References
Bioinformatics. 2009 Jul 15;25(14):1754-60
J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):196-203
J Neurochem. 2011 Oct;119(2):275-82
N Engl J Med. 2001 May 31;344(22):1688-700
Cited by 4192 citations (total)
Journal Article Research Support, Non-U.S. Gov't Review
Protein misdirection inside and outside motor neurons in Amyotrophic Lateral Sclerosis (ALS): a possible clue for therapeutic strategies.
Electronic publication date November 11, 2011
Akemi Ido [...] Makoto Urushitani et al.
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by progressive muscle wasting and weakness with no effective cure....
Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis.
Electronic publication date February 13, 2015
Luc Dupuis [...] Albert C Ludolph et al.
BACKGROUND
Pioglitazone, an oral anti-diabetic that stimulates the PPAR-gamma transcription factor, increased survival of mice with amyotrophic lateral sclerosis (ALS).
METHODS/PRINCIPAL FINDINGS
We...
Conflict of interest statement
MeSH
- •
- •
- •
- •
Specialties
- •
- •
Copyright
Copyright © 2011 Elsevier Inc. All rights reserved.